DOCSLIB.ORG

Gata2, Fli1, and Scl Form a Recursively Wired Gene-Regulatory Circuit During Early Hematopoietic Development

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gata2, Fli1, and Scl Form a Recursively Wired Gene-Regulatory Circuit During Early Hematopoietic Development Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development John E. Pimanda*†‡, Katrin Ottersbach*, Kathy Knezevic*, Sarah Kinston*, Wan Y. I. Chan*, Nicola K. Wilson*, Josette-Rene´ e Landry*, Andrew D. Wood*, Anja Kolb-Kokocinski§, Anthony R. Green*, David Tannahill§, Georges Lacaud¶, Valerie Kouskoff¶, and Berthold Go¨ ttgens*‡ *Department of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, United Kingdom; †Lowy Cancer Research Centre and Prince of Wales Clinical School, University of New South Wales, Sydney NSW 2052, Australia; §The Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom; and ¶Paterson Institute for Cancer Research, Manchester M20 4BX, United Kingdom Edited by Mark T. Groudine, Fred Hutchinson Cancer Research Center, Seattle, WA, and approved August 28, 2007 (received for review July 26, 2007) Conservation of the vertebrate body plan has been attributed to the up the subcircuit. Subcircuits that perform essential functions in evolutionary stability of gene-regulatory networks (GRNs). We de- building body parts have been termed the kernels of the GRN (16). scribe a regulatory circuit made up of Gata2, Fli1, and Scl/Tal1 and Disruption of TFs that make up the kernel often results in loss of their enhancers, Gata2-3, Fli1؉12, and Scl؉19, that operates during the body part, and hence the basic architecture of kernels is highly specification of hematopoiesis in the mouse embryo. We show that conserved through evolution (16). the Fli1؉12 enhancer, like the Gata2-3 and Scl؉19 enhancers, targets Scl, Gata2, and the Ets factor Fli1 are required for normal hematopoietic stem cells (HSCs) and relies on a combination of Ets, hematopoiesis in mice (reviewed in ref. 17) and are expressed in Gata, and E-Box motifs. We show that the Gata2-3 enhancer also uses avian hematopoietic clusters (18) and hematopoietic mesodermal a similar cluster of motifs and that Gata2, Fli1, and Scl are expressed precursors in frog and zebrafish embryos (19, 20). In this article we in embryonic day-11.5 dorsal aorta where HSCs originate and in fetal describe a GRN kernel composed of Gata2, Fli1, and Scl, and their liver where they multiply. The three HSC enhancers in these tissues respective cis-regulatory modules. Using transgenic mice and in vivo and in ES cell-derived hemangioblast equivalents are bound by each ChIP assays of embryonic hematopoietic tissues, we demonstrate of these transcription factors (TFs) and form a fully connected triad that this GRN kernel operates during key stages of mouse HSC that constitutes a previously undescribed example of both this net- specification in the aorta–gonad-mesonephros (AGM) region and work motif in mammalian development and a GRN kernel operating in the midgestation fetal liver (FL). during the specification of a mammalian stem cell. Results hemangioblast ͉ hematopoiesis ͉ hematopoietic stem cell ͉ The Fli1؉12 Hematopoietic Enhancer Targets Long-Term Repopulating network motif ͉ transcription factor network Blood Stem Cells in the Embryo. We have previously established that the Fli1ϩ12 enhancer directs lacZ expression to blood and endo- ematopoietic stem cells (HSCs) represent the best-character- theliuminF0 transgenic embryos (21). However, it was not known Hized adult multipotent stem cell population, with the availabil- whether the Fli1ϩ12 enhancer targeted expression to HSCs per se. ity of a plethora of markers and biological (clonogenic and trans- To evaluate the in vivo activity of the Fli1ϩ12 enhancer in detail, plantation) assays to identify long-term repopulating HSCs and we established stable transgenic lines (L5760 and L5754) with distinguish them from multipotent progenitors with only limited founders generated using a 500-bp fragment of the human self-renewal potential (1). Transcriptional regulation is a key mech- FLI1ϩ12 locus cloned downstream of the SV minimal promoter anism controlling the formation and subsequent behavior of HSCs and lacZ reporter (SV/lacZ/FLI1 ϩ 12 in Fig. 1Ai). Whole-mount (2). Both gain and loss of function studies have identified a number analysis of gastrulating embryonic day-7.5 (E7.5) embryos showed of transcription factors (TFs), including Scl/Tal 1 (3, 4), Gata2 (5) expression of the transgene in the region of extraembryonic me- and Runx1 (6, 7), as critical regulators of HSC development. soderm that characterizes primitive hematopoiesis in the early yolk Significantly, disruption of many of these TFs contributes to the sac (compare Fig. 1Aiii with Fig. 1Aii). This finding is consistent pathogenesis of hematological malignancies, emphasising the im- with expression in hematopoietic tissues and the vasculature during portance of transcriptional regulation in both normal and leukae- later stages of development (Fig. 1A iv–xiii). mic stem cells. To establish whether the Fli1ϩ12 enhancer-targeted expression Biological complexity does not correlate with gene number but to FL HSCs, we first characterized the surface phenotype of FL rather with the intricacy of gene regulation (8). Enhancers and cells targeted by the SV/lacZ/FLI1ϩ12 transgene. One of every 5.7 other cis-regulatory elements play a central role in the coordinated expression of genes and a number of tissue-specific regulatory elements of key HSC TFs, such as Scl and Gata2, have been Author contributions: J.E.P. and B.G. designed research; J.E.P., K.O., K.K., S.K., W.Y.I.C., identified (9–13). However, it is clear from studies in nonvertebrate N.K.W., J.-R.L., A.D.W., A.K.-K., G.L., and V.K. performed research; J.E.P., K.O., K.K., S.K., W.Y.I.C., N.K.W., J.-R.L., A.K.-K., A.R.G., D.T., G.L., V.K., and B.G. analyzed data; and J.E.P. model organisms, such as Drosophila and the sea urchin, that to and B.G. wrote the paper. comprehend developmental processes, it is necessary to move The authors declare no conflict of interest. beyond the study of individual genes and determine how regulatory This article is a PNAS Direct Submission. genes interact to form functional gene regulatory-networks (GRNs) (reviewed in ref. 14). Abbreviations: AGM, aorta–gonad-mesonephros; DA, dorsal aorta; En, embryonic day n; EB, embryoid body; FDG, fluoro-deoxy-D-glucose; FL, fetal liver; GRN, gene-regulatory Comprehensive analysis of the sea urchin endomesoderm GRN network; HSC, hematopoietic stem cell; TF, transcription factor. showed that they consist of assemblies of subcircuits made up of TF ‡To whom correspondence may be addressed. E-mail: [email protected] or genes and their target cis-regulatory modules, with each subcircuit [email protected]. performing a distinct regulatory function during development (15). This article contains supporting information online at www.pnas.org/cgi/content/full/ The linkages of these subcircuits are highly recursive with each 0707045104/DC1. cis-regulatory module receiving inputs from multiple TFs that make © 2007 by The National Academy of Sciences of the USA 17692–17697 ͉ PNAS ͉ November 6, 2007 ͉ vol. 104 ͉ no. 45 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0707045104 Downloaded by guest on September 25, 2021 Fig. 1. The FLI1ϩ12 hematopoi- etic enhancer targets blood stem A +12 B L5760 E12.5 Fetal Liver 10kb FLI1 Non transgenic 0.034% (i) cells. (A) The FLI1ϩ12 enhancer di- (i) rects reporter activity to blood and (i) SV-lacZ 500bp lacZ/FLI1 99.3% blood vessels. (i) Schematic diagram SV/ +12 of the human FLI1 locus. A fragment (ii)E7.5 (iii) E7.5 (iv) E9.5(v) E11.5 (vi) E12.5 (vii) of DNA corresponding to the FLI1ϩ12 region was used to gener- 0.003% (ii) 0 5 ate transgenic mice. (ii–vii) E7.5– C 1D S E12.5 X-Gal-stained whole-mount S FLI1 SV/lacZ +12/ C ϩ WT and L5760 SV/lacZ/FLI1 12 em- Non-TG TG (ii) (iii) bryos. (ii) E7.5 WT embryo with no (viii) (ix) (x) (xi) (xii) (xiii) 95.5% staining. (iii) E7.5 transgenic em- DA YS 0.245% (iii) Heart bryo showing staining within the DA extra-embryonic hematopoietic re- FL FL gion. (iv) E9.5 transgenic embryo 3.1552% showing staining of the heart x20 x40 x20 x40 x10 x20 lacZ CD48/41 chambers (boxed) and vitelline ves- sels (arrow). (v) E11.5 transgenic embryo showing staining within the FL (arrow) and blood vessels. (vi) E12.5 transgenic embryo showing staining in the vitelline vessels (arrow). (vii) Magnified view of the boxed area in vi showing FL staining (arrow). (viii–xiii) Paraffin sections of a E11.5 SV/lacZ/FLI1ϩ12 embryo. (viii) Sagittal section of the DA showing staining in the endothelium. (ix) High-power view of the DA showing staining in a hematopoietic cluster (arrow). (x) Section through the FL showing staining in hematopoietic cells. (xi) High-power view of x. (xii) Section through the yolk sac showing staining in the wall of a blood vessel. (xiii) Section through the heart showing endocardial staining. (B) Flow cytometry of FDG treated nontransgenic and transgenic E12.5 FLs from a litter of SV/lacZ/FLI1ϩ12 (L5760) ϫ WT crosses. CD150ϩ/CD48Ϫ/CD41Ϫ cells are enriched in the population targeted by the transgene. YS, yolk sac. CD150ϩ/CD48Ϫ/CD41Ϫ FL cells gives long-term multilineage re- hematopoietic regulatory elements of the Scl and Lyl1 genes (17, constitution in irradiated mice (22). FL cell suspensions were 23). Clustering of Ets and Gata sites [two Ets and one Gata site with prepared from E12.5 embryos and stained with the fluorescent defined spacing and orientation constraints constitutes the Ets/Ets/ ␤-galactosidase substrate, fluoro-deoxy-D-glucose (FDG). As Gata (E/E/G) signature] can be exploited in genome-wide compu- shown in Fig. 1B, Ϸ3% of FL cells from SV/lacZ/FLI1ϩ12 trans- tational screens to identify new hematopoietic stem/progenitor genic embryos express the transgene.
Load more

Recommended publications
  • Hippo/YAP Signaling Pathway: a Promising Therapeutic Target In
    Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers? Sarah Morice, Geoffroy Danieau, Françoise Rédini, Bénédicte Brounais-Le-Royer, Franck Verrecchia To cite this version: Sarah Morice, Geoffroy Danieau, Françoise Rédini, Bénédicte Brounais-Le-Royer, Franck Verrecchia. Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?. Can- cers, MDPI, 2020, 12 (3), pp.645. 10.3390/cancers12030645. inserm-03004096 HAL Id: inserm-03004096 https://www.hal.inserm.fr/inserm-03004096 Submitted on 13 Nov 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. cancers Review Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers? Sarah Morice, Geoffroy Danieau, Françoise Rédini, Bénédicte Brounais-Le-Royer and Franck Verrecchia * INSERM, UMR1238, Bone Sarcoma and Remodeling of Calcified Tissues, Nantes University, 44035 Nantes, France; [email protected] (S.M.); geoff[email protected] (G.D.); [email protected] (F.R.); [email protected] (B.B.-L.-R.) * Correspondence: [email protected]; Tel.: +33-244769116 Received: 4 February 2020; Accepted: 7 March 2020; Published: 10 March 2020 Abstract: Osteosarcoma and Ewing sarcoma are the most prevalent bone pediatric tumors.
    [Show full text]
  • FLI1 Gene Fli-1 Proto-Oncogene, ETS Transcription Factor
    FLI1 gene Fli-1 proto-oncogene, ETS transcription factor Normal Function The FLI1 gene provides instructions for making the FLI protein, which controls the activity (transcription) of genes. Transcription is the first step in the process of producing proteins. The FLI protein is part of a group of related proteins, called the Ets family of transcription factors, that control transcription. The FLI protein attaches (binds) to certain regions of DNA and turns on (activates) the transcription of nearby genes. The proteins produced from these genes control many important cellular processes, such as cell growth and division (proliferation), maturation (differentiation), and survival. The FLI protein is found primarily in blood cells and is thought to regulate their development. Health Conditions Related to Genetic Changes Ewing sarcoma Mutations involving the FLI1 gene cause a type of cancerous tumor known as Ewing sarcoma. These tumors develop in bones or soft tissues such as nerves and cartilage. There are several types of Ewing sarcoma, including Ewing sarcoma of bone, extraosseous Ewing sarcoma, peripheral primitive neuroectodermal tumor, and Askin tumor. The mutations that cause these tumors are acquired during a person's lifetime and are present only in the tumor cells. This type of genetic change, called a somatic mutation, is not inherited. The most common mutation that causes Ewing sarcoma is a rearrangement (translocation) of genetic material between chromosome 11 and chromosome 22. This translocation, written as t(11;22), fuses part of the FLI1 gene on chromosome 11 with part of another gene called EWSR1 on chromosome 22, creating an EWSR1/FLI1 fusion gene.
    [Show full text]
  • Accompanies CD8 T Cell Effector Function Global DNA Methylation
    Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M.
    [Show full text]
  • Supplementary Figure Legends
    1 Supplementary Figure legends 2 Supplementary Figure 1. 3 Experimental workflow. 4 5 Supplementary Figure 2. 6 IRF9 binding to promoters. 7 a) Verification of mIRF9 antibody by site-directed ChIP. IFNβ-stimulated binding of IRF9 to 8 the ISRE sequences of Mx2 was analyzed using BMDMs of WT and Irf9−/− (IRF9-/-) mice. 9 Cells were treated with 250 IU/ml of IFNβ for 1.5h. Data represent mean and SEM values of 10 three independent experiments. P-values were calculated using the paired ratio t-test (*P ≤ 11 0.05; **P ≤ 0.01, ***P ≤ 0.001). 12 b) Browser tracks showing complexes assigned as STAT-IRF9 in IFNγ treated wild type 13 BMDMs. Input, STAT2, IRF9 (scale 0-200). STAT1 (scale 0-150). 14 15 Supplementary Figure 3. 16 Experimental system for BioID. 17 a) Kinetics of STAT1, STAT2 and IRF9 synthesis in Raw 264.7 macrophages and wild type 18 BMDMs treated with 250 IU/ml as indicated. Whole-cell extracts were tested in western blot 19 for STAT1 phosphorylation at Y701 and of STAT2 at Y689 as well as total STAT1, STAT2, 20 IRF9 and GAPDH levels. The blots are representative of three independent experiments. b) 21 Irf9-/- mouse embryonic fibroblasts (MEFs) were transiently transfected with the indicated 22 expression vectors, including constitutively active IRF7-M15. One day after transfection, 23 RNA was isolated and Mx2 expression determined by qPCR. c) Myc-BirA*-IRF9 transgenic 24 Raw 264.7 were treated with increasing amounts of doxycycline (dox) (0,2µg/ml, 0,4µg/ml, 25 0,6µg/ml, 0,8µg/ml, 1mg/ml) and 50µM biotin.
    [Show full text]
  • Genome-Wide Analysis of the Zebrafish ETS Family Identifies Three Genes Required for Hemangioblast Differentiation Or Angiogenesis
    Genome-Wide Analysis of the Zebrafish ETS Family Identifies Three Genes Required for Hemangioblast Differentiation or Angiogenesis Feng Liu, Roger Patient Abstract—ETS domain transcription factors have been linked to hematopoiesis, vasculogenesis, and angiogenesis. However, their biological functions and the mechanisms of action, remain incompletely understood. Here, we have performed a systematic analysis of zebrafish ETS domain genes and identified 31 in the genome. Detailed gene expression profiling revealed that 12 of them are expressed in blood and endothelial precursors during embryonic development. Combined with a phylogenetic tree assay, this suggests that some of the coexpressed genes may have redundant or additive functions in these cells. Loss-of-function analysis of 3 of them, erg, fli1, and etsrp, demonstrated that erg and fli1 act cooperatively and are required for angiogenesis possibly via direct regulation of an endothelial cell junction molecule, VE-cadherin, whereas etsrp is essential for primitive myeloid/endothelial progenitors (hemangio- blasts) in zebrafish. Taken together, these results provide a global view of the ETS genes in the zebrafish genome during embryogenesis and provide new insights on the functions and biology of erg, fli1, and etsrp, which could be applicable to higher vertebrates, including mice and humans. (Circ Res. 2008;103:1147-1154.) Key Words: zebrafish Ⅲ gene duplication Ⅲ ETS transcription factors Ⅲ hemangioblast Ⅲ angiogenesis ebrafish has been recognized as an excellent genetic and during embryonic development and adulthood and have been Zdevelopmental biology model to study hematopoiesis linked with diverse biological processes, from hematopoiesis, and vessel development. Large numbers of genetic mutants vasculogenesis, and angiogenesis to neurogenesis. Many and transgenic lines in both blood and endothelial lineages important blood and endothelial regulators have well- have become available.
    [Show full text]
  • Supplementary Information
    STEAP1 is associated with Ewing tumor invasiveness SUPPLEMENTARY INFORMATION: SUPPLEMENTARY METHODS: Primer sequences for qRT-PCR For EWS/FLI1 detection, the following primers 5’-TAGTTACCCACCCCAAACTGGAT-3’ (sense), 5’-GGGCCGTTGCTCTGTATTCTTAC-3’ (antisense), and probe 5’-FAM- CAGCTACGGGCAGCA-3’ were used. The concentration of primers and probes were 900 and 250 nM, respectively. Inventoried TaqMan Gene Expression Assays (Applied Biosystems) were used for ADIPOR1 (Hs01114951_m1), GAPDH (Hs00185180_m1), USP18 (Hs00276441_m1), TAP1 (Hs00184465_m1), DTX3L (Hs00370540_m1), PSMB9 (Hs00160610_m1), MMP-1 (Hs00899658_m1), STAT1 (Hs01013996_m1) and STEAP1 (Hs00248742_m1). Constructs and retroviral gene transfer The cDNA encoding EWS/FLI1 was described previously (1). A BglII fragment was subcloned in pMSCVneo (Takara Bio Europe/Clontech). For STEAP1-overexpression STEAP1 coding cDNA was cloned into pMSCVneo. For stable STEAP1 silencing, oligonucleotides of the short hairpin corresponding to the siRNAs were cloned into pSIREN-RetroQ (Takara Bio Europe/Clontech). Retroviral constructs were transfected by electroporation into PT67 cells. Viral infection of target cells was carried out in presence of 4 µg/mL polybrene. Infectants were selected in 600 µg/mL G418 (pMSCVneo) or 2 µg/mL puromycin (pSIREN-RetroQ), respectively. Chromatin-immunoprecipitation (ChIP) 2x107 SK-N-MC and RH-30 cells were fixed in 1% formaldehyde for 8 min. Samples were sonicated to an average DNA length of 500-1000 bp. ChIP was performed with 5 µg of anti-FLI1- antibody (C-19; Santa Cruz, Heidelberg, Germany) added to 0.5 mg of precleared chromatin. page 1 of 23 STEAP1 is associated with Ewing tumor invasiveness Quantitative PCR of immunoprecipitated DNA was performed using SybrGreen (Thermo Fisher Scientific, Dreieich, Germany). FLI1 data of the SK-N-MC cells at individual genomic loci were normalized to the control cell line RH-30, and standardized to a non-regulated genomic locus outside of the STEAP1 locus.
    [Show full text]
  • Germline Variants in ETV6 Underlie Reduced Platelet Formation, Platelet Dysfunction and Increased Levels of Circulating CD34+ Progenitors
    Germline variants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of circulating CD34+ progenitors. Marjorie Poggi, Matthias Canault, Marie Favier, Ernest Turro, Paul Saultier, Dorsaf Ghalloussi, Veronique Baccini, Lea Vidal, Anna Mezzapesa, Nadjim Chelghoum, et al. To cite this version: Marjorie Poggi, Matthias Canault, Marie Favier, Ernest Turro, Paul Saultier, et al.. Germline vari- ants in ETV6 underlie reduced platelet formation, platelet dysfunction and increased levels of cir- culating CD34+ progenitors.. Haematologica, Ferrata Storti Foundation, 2017, 102 (2), pp.282-294. 10.3324/haematol.2016.147694. hal-01478347 HAL Id: hal-01478347 https://hal.archives-ouvertes.fr/hal-01478347 Submitted on 22 Apr 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. ARTICLE Platelet Biology & Its Disorders Germline variants in ETV6 underlie reduced Ferrata Storti EUROPEAN Foundation platelet formation, platelet dysfunction and HEMATOLOGY + ASSOCIATION increased levels of circulating CD34 progenitors Marjorie Poggi,1,* Matthias Canault,1,* Marie Favier,1,2,* Ernest Turro,3,4,* Paul Saultier,1 Dorsaf Ghalloussi,1 Veronique Baccini,1 Lea Vidal,1 Anna Mezzapesa,1 Nadjim Chelghoum,5 Badreddine Mohand-Oumoussa,5 Haematologica 2017 Céline Falaise,6 Rémi Favier,7 Willem H.
    [Show full text]
  • The Activation of Human Dermal Microvascular Cells by Poly(I:C)
    The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A This information is current as Pathway of September 24, 2021. Lukasz Stawski, Grace Marden and Maria Trojanowska J Immunol published online 15 November 2017 http://www.jimmunol.org/content/early/2017/11/14/jimmun ol.1601968 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/11/14/jimmunol.160196 Material 8.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 24, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published November 15, 2017, doi:10.4049/jimmunol.1601968 The Journal of Immunology The Activation of Human Dermal Microvascular Cells by Poly(I:C), Lipopolysaccharide, Imiquimod, and ODN2395 Is Mediated by the Fli1/FOXO3A Pathway Lukasz Stawski, Grace Marden, and Maria Trojanowska Endothelial cell (EC) dysfunction has been associated with inflammatory and autoimmune diseases; however, the factors contributing to this dysfunction have not been fully explored.
    [Show full text]
  • Y-Box Binding Protein-1 Regulates Cell Proliferation and Is Associated with Clinical Outcomes of Osteosarcoma
    FULL PAPER British Journal of Cancer (2013) 108, 836–847 | doi: 10.1038/bjc.2012.579 Keywords: osteosarcoma (OS); Y-box binding protein-1 (YB-1); cell proliferation; atelocollagen Y-box binding protein-1 regulates cell proliferation and is associated with clinical outcomes of osteosarcoma Y Fujiwara-Okada1, Y Matsumoto*,1, J Fukushi1, N Setsu1,2, S Matsuura1,2, S Kamura1, T Fujiwara1, K Iida1, M Hatano1, A Nabeshima1, H Yamada3, M Ono4, Y Oda2 and Y Iwamoto1 1Department of Orthopaedic Surgery, Kyushu University, Fukuoka, Japan; 2Department of Anatomic Pathology, Kyushu University, Fukuoka, Japan; 3Department of the Division of Host Defense, Kyushu University, Fukuoka, Japan and 4Department of Pharmaceutical Oncology, Kyushu University, Fukuoka, Japan Background: Prognosis of osteosarcoma (OS) with distant metastasis and local recurrence is still poor. Y-box binding protein-1 (YB-1) is a multifunctional protein that can act as a regulator of transcription and translation and its high expression of YB-1 protein was observed in OS, however, the role of YB-1 in OS remains unclear. Methods: Y-box binding protein-1 expression in OS cells was inhibited by specific small interfering RNAs to YB-1 (si-YB-1). The effects of si-YB-1 in cell proliferation and cell cycle transition in OS cells were analysed in vitro and in vivo. The association of nuclear expression of YB-1 and clinical prognosis was also investigated by immunohistochemistry. Results: Proliferation of OS cell was suppressed by si-YB-1 in vivo and in vitro. The expression of cyclin D1 and cyclin A were also decreased by si-YB-1.
    [Show full text]
  • Novel Mechanisms of Transcriptional Regulation by Leukemia Fusion Proteins
    Novel mechanisms of transcriptional regulation by leukemia fusion proteins A dissertation submitted to the Graduate School of the University of Cincinnati in partial fulfillment of the requirement for the degree of Doctor of Philosophy in the Department of Cancer and Cell Biology of the College of Medicine by Chien-Hung Gow M.S. Columbia University, New York M.D. Our Lady of Fatima University B.S. National Yang Ming University Dissertation Committee: Jinsong Zhang, Ph.D. Robert Brackenbury, Ph.D. Sohaib Khan, Ph.D. (Chair) Peter Stambrook, Ph.D. Song-Tao Liu, Ph.D. ABSTRACT Transcription factors and chromatin structure are master regulators of homeostasis during hematopoiesis. Regulatory genes for each stage of hematopoiesis are activated or silenced in a precise, finely tuned manner. Many leukemia fusion proteins are produced by chromosomal translocations that interrupt important transcription factors and disrupt these regulatory processes. Leukemia fusion proteins E2A-Pbx1 and AML1-ETO involve normal function transcription factor E2A, resulting in two distinct types of leukemia: E2A-Pbx1 t(1;19) acute lymphoblastic leukemia (ALL) and AML1-ETO t(8;21) acute myeloid leukemia (AML). E2A, a member of the E-protein family of transcription factors, is a key regulator in hematopoiesis that recruits coactivators or corepressors in a mutually exclusive fashion to regulate its direct target genes. In t(1;19) ALL, the E2A portion of E2A-Pbx1 mediates a robust transcriptional activation; however, the transcriptional activity of wild-type E2A is silenced by high levels of corepressors, such as the AML1-ETO fusion protein in t(8;21) AML and ETO-2 in hematopoietic cells.
    [Show full text]
  • Brd4-Bound Enhancers Drive Cell-Intrinsic Sex Differences in Glioblastoma
    Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma Najla Kfourya,b,1, Zongtai Qic,d,1, Briana C. Pragere,f, Michael N. Wilkinsonc,d, Lauren Broestla,g, Kristopher C. Berretth, Arnav Moudgilc,d,g, Sumithra Sankararamanc,d, Xuhua Chenc,d, Jason Gertzh, Jeremy N. Riche,i, Robi D. Mitrac,d,2,3, and Joshua B. Rubina,j,2,3 aDepartment of Pediatrics, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; bDepartment of Neurological Surgery, University of California San Diego, La Jolla, CA 92037; cDepartment of Genetics, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; dCenter for Genome Sciences and Systems Biology, Washington University in St. Louis, St. Louis, MO 63110; eDivision of Regenerative Medicine, Department of Medicine, University of California San Diego, La Jolla, CA 92037; fCleveland Clinic Lerner College of Medicine, Cleveland, OH 44195; gMedical Scientist Training Program, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110; hDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112; iDepartment of Neurosciences, University of California San Diego, La Jolla, CA 92037; and jDepartment of Neuroscience, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110 Edited by Rene Bernards, The Netherlands Cancer Institute, Amsterdam, The Netherlands, and approved December 25, 2020 (received for review August 21, 2020) Sex can be an important determinant of cancer phenotype, and cancer risk and progression, with the ultimate goal of incorporating exploring sex-biased tumor biology holds promise for identifying sex-informed approaches to treatment to improve survival of all novel therapeutic targets and new approaches to cancer treatment.
    [Show full text]
  • The ETV6-NTRK3 Gene Fusion Encodes a Chimeric Protein Tyrosine Kinase That Transforms NIH3T3 Cells
    Oncogene (2000) 19, 906 ± 915 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells Daniel H Wai1, Stevan R Knezevich1, Trevor Lucas2,3, Burkhard Jansen2,3, Robert J Kay4 and Poul HB Sorensen*,1 1Department of Pathology, 4480 Oak St., British Columbia's Children's Hospital, Vancouver, British Columbia V6H 3V4, Canada; 2Department of Clinical Pharmacology, Section of Experimental Oncology/Molecular Pharmacology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; 3Department of Dermatology, Division of General Dermatology, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria; 4Department of Medical Genetics, Terry Fox Laboratory, British Columbia Cancer Agency, 600 W. 10th Avenue, Vancouver, British Columbia, V5Z 4E6, Canada The congenital ®brosarcoma t(12;15)(p13;q25) rearran- Introduction gement splices the ETV6 (TEL) gene on chromosome 12p13 in frame with the NTRK3 (TRKC) neurotrophin-3 Congenital ®brosarcoma (CFS) is a cellular, mitotically receptor gene on chromosome 15q25. Resultant ETV6- active neoplasm of the soft tissues primarily aecting NTRK3 fusion transcripts encode the helix ± loop ± helix infants less than 1 year of age. It is a spindle cell (HLH) dimerization domain of ETV6 fused to the sarcoma which may grow to enormous sizes and can protein tyrosine kinase (PTK) domain of NTRK3. We cause considerable morbidity or mortality. Although show here that ETV6-NTRK3 homodimerizes and is CFS has a high propensity for local recurrence, this capable of forming heterodimers with wild-type ETV6.
    [Show full text]